We have located links that may give you full text access.
Stability of Prognostic Estimation Using the CAPRA Score Incorporating Imaging-Based vs Physical Exam-Based Staging.
Journal of Urology 2023 April 27
PURPOSE: Although official T-staging criteria for prostate cancer center on digital rectal examination (DRE) findings, providers increasingly rely on transrectal ultrasonography (TRUS) and magnetic resonance imaging (MRI) to define pragmatic clinical stage to guide management. We assessed the impact of incorporating imaging findings into T-staging on performance of a well-validated prognostic instrument.
MATERIALS AND METHODS: Patients who underwent radical prostatectomy for prostate cancer diagnosed between 2000-2019 with stage ≤cT3a on both DRE and imaging (TRUS/MRI) were included. The UCSF-CAPRA score was computed 2 ways: (1) incorporating DRE-based T-stage and (2) incorporating imaging-based T-stage. We assessed for risk changes across the 2 methods and associations of CAPRA (by both methods) with biochemical recurrence (BCR), using unadjusted and adjusted Cox proportional hazards models. Model discrimination and net benefit were assessed with time-dependent area under the curve (AUC) and decision curve analysis, respectively.
RESULTS: Of 2222 men included, 377 (17%) increased in CAPRA score with imaging-based staging ( P < .01). DRE-based (HR 1.54; 95% CI 1.48-1.61) and imaging-based (HR 1.52; 95% CI 1.46-1.58) CAPRA scores were comparably accurate for predicting recurrence with similar discrimination and decision curve analyses. On multivariable Cox regression, positive DRE at diagnosis (HR 1.29; 95% CI 1.09-1.53) and imaging-based clinical T3/4 disease (HR 1.72; 95% CI 1.43-2.07) were independently associated with BCR.
CONCLUSION: The CAPRA score remains accurate whether determined using imaging-based staging or DRE-based staging, with relatively minor discrepancies and similar associations with BCR. Staging information from either modality can be used in the CAPRA score calculation and still reliably predict risk of BCR.
MATERIALS AND METHODS: Patients who underwent radical prostatectomy for prostate cancer diagnosed between 2000-2019 with stage ≤cT3a on both DRE and imaging (TRUS/MRI) were included. The UCSF-CAPRA score was computed 2 ways: (1) incorporating DRE-based T-stage and (2) incorporating imaging-based T-stage. We assessed for risk changes across the 2 methods and associations of CAPRA (by both methods) with biochemical recurrence (BCR), using unadjusted and adjusted Cox proportional hazards models. Model discrimination and net benefit were assessed with time-dependent area under the curve (AUC) and decision curve analysis, respectively.
RESULTS: Of 2222 men included, 377 (17%) increased in CAPRA score with imaging-based staging ( P < .01). DRE-based (HR 1.54; 95% CI 1.48-1.61) and imaging-based (HR 1.52; 95% CI 1.46-1.58) CAPRA scores were comparably accurate for predicting recurrence with similar discrimination and decision curve analyses. On multivariable Cox regression, positive DRE at diagnosis (HR 1.29; 95% CI 1.09-1.53) and imaging-based clinical T3/4 disease (HR 1.72; 95% CI 1.43-2.07) were independently associated with BCR.
CONCLUSION: The CAPRA score remains accurate whether determined using imaging-based staging or DRE-based staging, with relatively minor discrepancies and similar associations with BCR. Staging information from either modality can be used in the CAPRA score calculation and still reliably predict risk of BCR.
Full text links
Related Resources
Trending Papers
The New Challenge of Obesity - Obesity-Associated Nephropathy.Diabetes, Metabolic Syndrome and Obesity 2024
Advances in Clinical Cardiology 2023: A Summary of Key Clinical Trials.Advances in Therapy 2024 May 15
Oral Anticoagulation Use in Individuals With Atrial Fibrillation and Chronic Kidney Disease: A Review.Seminars in Nephrology 2024 May 15
Nutrition in the intensive care unit: from the acute phase to beyond.Intensive Care Medicine 2024 May 22
Drug Therapy for Acute and Chronic Heart Failure with Preserved Ejection Fraction with Hypertension: A State-of-the-Art Review.American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions 2024 April 5
Sodium-glucose co-transporter protein 2 (SGLT2) inhibitors for people with chronic kidney disease and diabetes.Cochrane Database of Systematic Reviews 2024 May 22
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app